MedTrace Logo

Pre-therapeutic Analysis of the Individual Radiosensitivity of Cancer Patients in Luxembourg (APRI-Lux): Prospective National Interventional Study With Minimal Risk

NCT05433974 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2022-06-27

No results posted yet for this study

Summary

Pre-therapeutic analysis of the individual radiosensitivity of cancer patients in Luxembourg

Conditions

  • Radiosensitivity
  • Cancer
  • Radiation Toxicity

Interventions

BIOLOGICAL

Blood sample collection

Blood sample collection : 2 X 6 mL

Sponsors & Collaborators

  • BIONEXT

    collaborator UNKNOWN

  • Neolys

    collaborator INDUSTRY

  • Centre Francois Baclesse, Luxembourg

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2024-06-01
Completion
2024-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433974 on ClinicalTrials.gov